-
Vishal Mega Mart
129.95 134.50(%) -
Reliance Industr
1,425.80 1,115.55(%) -
Infosys
1,647.70 2,006.80(%) -
Sterlite Tech.
119.00 109.09(%) -
HDFC Bank
1,919.55 1,588.50(%) -
Varun Beverages
469.50 419.40(%) -
ICICI Bank
1,417.60 1,101.00(%) -
TCS
3,522.30 4,585.90(%) -
Happiest Minds
674.00 955.00(%) -
Mazagon Dock
3,342.85 3,778.00(%) -
Garden Reach Sh.
3,205.00 3,528.00(%) -
Bharti Airtel
1,847.50 1,373.05(%) -
M & M
2,993.70 2,360.45(%) -
Kotak Mah. Bank
2,129.90 1,679.10(%) -
Tata Motors
672.00 542.55(%) -
Cochin Shipyard
2,244.10 2,977.10(%) -
Hind. Unilever
2,334.10 3,034.50(%) -
Sun Pharma.Inds.
1,641.40 1,461.40(%) -
St Bk of India
790.75 679.65(%) -
HCL Technologies
1,738.00 2,011.00(%)
- Overview
- Key Ratios
- Financials
- Shareholding
- Company Info
- Peer Comparison
- Overview
- Key Ratios
- Financials
- Shareholding
- Company Info
- Peer Comparison
Sanofi India Ltd Pharmaceuticals - Multinational
- MNC Asc-Hoechst
- BSE Code : 256.0
- ISIN : INE058A01010
-
Today’s Low
6,045.00 -
Today’s High
6,155.00

-
Open
6,112.50 -
Perv Close
6,147.50 -
52W Low
4,902.00 -
52W High
7,600.00
Key Indicators
-
P/E(TTM)
37.25
-
Mar.Cap (₹Cr.)
14,109.33
-
Div & Yield %
1.90
-
Book Value(₹)
373.70
-
Debt-Equity Ratio
-0.34
-
AGM Date
16-Jun-2025
-
EPS
164.93
-
P/E Ratio
37.25
Financials Ratios
-
Debt-Equity Ratio
-
-
Mar.Cap (₹Cr.)
14,109.33
-
RONW (%)
-
-
ROCE (%)
-
Score Board
-
Equity (₹ in Cr.)
23.03
-
BV (₹)
373.70
-
Sales( ₹ in Cr.)
2,013.20
-
NP (in Cr.)
442.27
-
NP Var(%)
-25.0
-
Div%
1170.0
-
CPS (₹)
208.00
-
EPS (₹)
192.00
-
Traded Value (₹ in Lakhs)
14,150.21
-
52 Week High
7,600.00
-
52 Week Low
4,902.00
-
Price BSE
6144.0
-
Price NSE
6,127.00
-
Market Capital( in Cr.)
14,150.21
-
P/C Ratio
29.50
-
P/E Ratio
32.00
-
Price Vs.BV
192.00
-
15-May-2025( 07:40)
Results - Announcements - Sanof... - Net profit of Sanofi India dec...
-
10-May-2025( 10:52)
Corporate News - Sanof... - Sanofi India will hold a meeti...
-
11-Apr-2025( 11:01)
Hot Pursuit - Sanof... - <p> The board of directors acc...
-
19-Mar-2025( 12:01)
Corporate News - Sanof... - Sanofi India announced that th...
Navigate The Market With Confidence
Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions
Financials
All Values are in (₹Cr)Particulars(INCOME) | 2024 Dec | 2023 Dec | 2022 Dec | 2021 Dec | 2020 Dec | 2019 Dec |
---|---|---|---|---|---|---|
INCOME : | ||||||
Sales Turnover | 2,013.20 | 1,996.10 | 2,770.10 | 2,956.60 | 2,901.90 | 3,070.60 |
Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Sales | 2,013.20 | 1,996.10 | 2,770.10 | 2,956.60 | 2,901.90 | 3,070.60 |
Other Income | 116.30 | 317.60 | 203.50 | 563.60 | 89.80 | 94.10 |
Stock Adjustments | -60.20 | 283.70 | 11.10 | -43.10 | -57.50 | -2.30 |
Total Income | 2,069.30 | 2,597.40 | 2,984.70 | 3,477.10 | 2,934.20 | 3,162.40 |
EXPENDITURE : | ||||||
Raw Materials | 919.10 | 1,237.20 | 1,200.70 | 1,263.70 | 1,196.10 | 1,345.10 |
Power and Fuel Cost | 11.60 | 8.40 | 14.30 | 13.90 | 23.60 | 42.30 |
Employee Cost | 240.20 | 280.70 | 405.90 | 433.90 | 460.80 | 449.70 |
Other Manufacturing Expenses | 34.20 | 26.00 | 74.30 | 73.70 | 90.30 | 77.30 |
Selling and Administration Expenses | 212.10 | 192.70 | 315.70 | 306.90 | 306.80 | 433.80 |
Miscellaneous Expenses | 82.70 | 47.10 | 65.90 | 58.90 | 95.40 | 114.10 |
Employee Benefit Expenses | 240.20 | 280.70 | 405.90 | 433.90 | 460.80 | 449.70 |
Less: Preoperative Expenditure | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Total Expenses | 1,499.90 | 1,792.10 | 2,076.80 | 2,151.00 | 2,173.00 | 2,462.30 |
Operating Profit | 569.40 | 805.30 | 907.90 | 1,326.10 | 761.20 | 700.10 |
Interest | 1.50 | 1.70 | 1.70 | 1.80 | 1.80 | 0.30 |
Gross Profit | 567.90 | 803.60 | 906.20 | 1,324.30 | 759.40 | 699.80 |
Depreciation | 36.70 | 36.50 | 41.90 | 66.70 | 82.20 | 99.90 |
Profit Before Tax | 531.20 | 767.10 | 864.30 | 1,257.60 | 677.20 | 599.90 |
Current Tax | 125.80 | 163.40 | 245.20 | 336.00 | 211.00 | 227.60 |
Fringe Benefit tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Deferred Tax | -8.10 | 0.50 | -1.50 | -22.80 | -11.40 | -41.90 |
Reported Net Profit | 413.50 | 603.20 | 620.60 | 944.40 | 477.60 | 414.20 |
Extraordinary Items | -28.77 | 14.00 | 94.55 | 363.33 | -30.63 | -37.98 |
Adjusted Net Profit | 442.27 | 589.20 | 526.05 | 581.07 | 508.23 | 452.18 |
Adjustment below Net Profit | -185.00 | -1.30 | 0.50 | -3.30 | -8.80 | -16.50 |
P & L Balance brought forward | 601.90 | 843.20 | 1,795.10 | 1,694.60 | 2,029.60 | 1,815.10 |
Statutory Appropriations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Appropriations | 384.60 | 843.20 | 1,573.00 | 840.60 | 803.80 | 183.20 |
P & L Balance carried down | 445.80 | 601.90 | 843.20 | 1,795.10 | 1,694.60 | 2,029.60 |
Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Preference Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Equity Dividend (%) | 1,170.00 | 1,670.00 | 5,700.00 | 4,900.00 | 3,650.00 | 3,490.00 |
Dividend Per Share(Rs) | 117.00 | 167.00 | 570.00 | 490.00 | 365.00 | 349.00 |
Earnings Per Share-Unit Curr | 179.78 | 262.26 | 269.83 | 410.61 | 207.65 | 180.09 |
Earnings Per Share(Adj)-Unit Curr | 179.78 | 262.26 | 269.83 | 410.61 | 207.65 | 180.09 |
Book Value | 374.17 | 441.52 | 554.70 | 967.65 | 921.30 | 1,061.87 |
Book Value(Adj)-Unit Curr | 374.17 | 441.52 | 554.70 | 967.65 | 921.30 | 1,061.87 |